Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eszopiclone versus zopiclone versus placebo crossover study of next-day residual effects in healthy adults
2008-000406-36Phase 4Completed
- Sponsor
- GSK
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of eszopiclone and zopiclone (6 arms), sponsored by GSK. Primary endpoint: Mean Tracking Error on Continuous Tracking Test. Started Apr 2008; status: completed.
02
Drugs
eszopiclonezopiclone
Beyond the preview
Go deeper on 2008-000406-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000406-36.